FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2133673951> ?p ?o ?g. }

• W2133673951 endingPage "3216" @default.
• W2133673951 startingPage "3213" @default.
• W2133673951 abstract "ABSTRACT The therapeutic success of an antiretroviral salvage regimen containing protease inhibitors (PI) is limited by PI-resistant viral strains exhibiting various degrees of resistance and cross-resistance. To evaluate the extent of cross-resistance to the new PI amprenavir, 155 samples from 132 human immunodeficiency virus type 1-infected patients were analyzed for viral genotype by direct sequencing of the protease gene. Concomitantly, drug sensitivity to indinavir, saquinavir, ritonavir, nelfinavir, and amprenavir was analyzed by a recombinant virus assay. A total of 111 patients had been pretreated with 1-4 PI, but all were naive to amprenavir. A total of 105 samples (67.7%) were sensitive to amprenavir; 25 samples (16.1%) were intermediately resistant, and another 25 samples were highly resistant (4- to 8-fold- and >8-fold-reduced sensitivity, respectively). The mutations 46I/L, 54L/V, 84V, and 90M showed the strongest association with amprenavir resistance ( P < 0.0001). The scoring system using 84V and/or any two of a number of mutations (10I/R/V/F, 46I/L, 54L/V, and 90M) predicted amprenavir resistance with a sensitivity of 86.0% and a specificity of 81.0% within the analyzed group of samples. Of 62 samples with resistance against 4 PI, 23 (37.1%) were still sensitive to amprenavir. In comparison, only 2 of 23 samples (8.7%) from nelfinavir-naive patients with resistance against indinavir, saquinavir, and ritonavir were still sensitive to nelfinavir. Amprenavir thus appears to be an interesting alternative for PI salvage therapy." @default.
• W2133673951 created "2016-06-24" @default.
• W2133673951 creator A5021555330 @default.
• W2133673951 creator A5042917012 @default.
• W2133673951 creator A5073708478 @default.
• W2133673951 creator A5085866340 @default.
• W2133673951 creator A5086466371 @default.
• W2133673951 creator A5089186770 @default.
• W2133673951 date "2000-11-01" @default.
• W2133673951 modified "2023-10-10" @default.
• W2133673951 title "Low Level of Cross-Resistance to Amprenavir (141W94) in Samples from Patients Pretreated with Other Protease Inhibitors" @default.
• W2133673951 cites W1966404588 @default.
• W2133673951 cites W1997781503 @default.
• W2133673951 cites W1997844736 @default.
• W2133673951 cites W1999313755 @default.
• W2133673951 cites W2007085875 @default.
• W2133673951 cites W2015203095 @default.
• W2133673951 cites W2032381212 @default.
• W2133673951 cites W2037036212 @default.
• W2133673951 cites W2049572613 @default.
• W2133673951 cites W2071136320 @default.
• W2133673951 cites W2097961569 @default.
• W2133673951 cites W2099509337 @default.
• W2133673951 cites W2122799540 @default.
• W2133673951 cites W2138042650 @default.
• W2133673951 cites W2160271466 @default.
• W2133673951 cites W2165080361 @default.
• W2133673951 cites W2171105848 @default.
• W2133673951 cites W2266830467 @default.
• W2133673951 cites W2314026148 @default.
• W2133673951 cites W2318289184 @default.
• W2133673951 cites W2325936580 @default.
• W2133673951 cites W3191029699 @default.
• W2133673951 doi "https://doi.org/10.1128/aac.44.11.3213-3216.2000" @default.
• W2133673951 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/101637" @default.
• W2133673951 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11036057" @default.
• W2133673951 hasPublicationYear "2000" @default.
• W2133673951 type Work @default.
• W2133673951 sameAs 2133673951 @default.
• W2133673951 citedByCount "43" @default.
• W2133673951 countsByYear W21336739512014 @default.
• W2133673951 countsByYear W21336739512015 @default.
• W2133673951 crossrefType "journal-article" @default.
• W2133673951 hasAuthorship W2133673951A5021555330 @default.
• W2133673951 hasAuthorship W2133673951A5042917012 @default.
• W2133673951 hasAuthorship W2133673951A5073708478 @default.
• W2133673951 hasAuthorship W2133673951A5085866340 @default.
• W2133673951 hasAuthorship W2133673951A5086466371 @default.
• W2133673951 hasAuthorship W2133673951A5089186770 @default.
• W2133673951 hasBestOaLocation W21336739512 @default.
• W2133673951 hasConcept C114851261 @default.
• W2133673951 hasConcept C142462285 @default.
• W2133673951 hasConcept C159047783 @default.
• W2133673951 hasConcept C181199279 @default.
• W2133673951 hasConcept C2522874641 @default.
• W2133673951 hasConcept C2776452011 @default.
• W2133673951 hasConcept C2776714187 @default.
• W2133673951 hasConcept C2776937687 @default.
• W2133673951 hasConcept C2777210460 @default.
• W2133673951 hasConcept C2777363262 @default.
• W2133673951 hasConcept C2777583353 @default.
• W2133673951 hasConcept C2779298103 @default.
• W2133673951 hasConcept C2780727368 @default.
• W2133673951 hasConcept C2781160516 @default.
• W2133673951 hasConcept C2993143319 @default.
• W2133673951 hasConcept C55493867 @default.
• W2133673951 hasConcept C71924100 @default.
• W2133673951 hasConcept C86803240 @default.
• W2133673951 hasConcept C89423630 @default.
• W2133673951 hasConceptScore W2133673951C114851261 @default.
• W2133673951 hasConceptScore W2133673951C142462285 @default.
• W2133673951 hasConceptScore W2133673951C159047783 @default.
• W2133673951 hasConceptScore W2133673951C181199279 @default.
• W2133673951 hasConceptScore W2133673951C2522874641 @default.
• W2133673951 hasConceptScore W2133673951C2776452011 @default.
• W2133673951 hasConceptScore W2133673951C2776714187 @default.
• W2133673951 hasConceptScore W2133673951C2776937687 @default.
• W2133673951 hasConceptScore W2133673951C2777210460 @default.
• W2133673951 hasConceptScore W2133673951C2777363262 @default.
• W2133673951 hasConceptScore W2133673951C2777583353 @default.
• W2133673951 hasConceptScore W2133673951C2779298103 @default.
• W2133673951 hasConceptScore W2133673951C2780727368 @default.
• W2133673951 hasConceptScore W2133673951C2781160516 @default.
• W2133673951 hasConceptScore W2133673951C2993143319 @default.
• W2133673951 hasConceptScore W2133673951C55493867 @default.
• W2133673951 hasConceptScore W2133673951C71924100 @default.
• W2133673951 hasConceptScore W2133673951C86803240 @default.
• W2133673951 hasConceptScore W2133673951C89423630 @default.
• W2133673951 hasIssue "11" @default.
• W2133673951 hasLocation W21336739511 @default.
• W2133673951 hasLocation W21336739512 @default.
• W2133673951 hasLocation W21336739513 @default.
• W2133673951 hasOpenAccess W2133673951 @default.
• W2133673951 hasPrimaryLocation W21336739511 @default.
• W2133673951 hasRelatedWork W1986393040 @default.
• W2133673951 hasRelatedWork W1988121816 @default.
• W2133673951 hasRelatedWork W2022580473 @default.
• W2133673951 hasRelatedWork W2032381212 @default.

• next